表紙:合成生物学の世界市場 (~2026年):ツール (オリゴヌクレオチド・酵素・合成細胞)・技術 (遺伝子合成・ゲノムエンジニアリング)・用途 (組織再生・バイオ燃料・消費者ケア・食品&農業・環境)・地域別
市場調査レポート
商品コード
1007811

合成生物学の世界市場 (~2026年):ツール (オリゴヌクレオチド・酵素・合成細胞)・技術 (遺伝子合成・ゲノムエンジニアリング)・用途 (組織再生・バイオ燃料・消費者ケア・食品&農業・環境)・地域別

Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Gene Synthesis, Genome Engineering), Application(Tissue Regeneration, Biofuel, Consumer Care, Food & Agriculture, Environmental) & Region-Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 359 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
合成生物学の世界市場 (~2026年):ツール (オリゴヌクレオチド・酵素・合成細胞)・技術 (遺伝子合成・ゲノムエンジニアリング)・用途 (組織再生・バイオ燃料・消費者ケア・食品&農業・環境)・地域別
出版日: 2021年05月24日
発行: MarketsandMarkets
ページ情報: 英文 359 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の合成生物学の市場規模は予測期間中26.5%のCAGRで推移し、2021年の95億米ドルから、2026年には307億米ドルの規模に成長すると予測されています。

合成遺伝子および合成細胞に対する需要の高まり、合成生物学の幅広い用途、DNAシーケンシングと合成のコストの低下、R&D資金とイニシアチブの増加、市場への投資の増加などの要因が同市場の成長を推進しています。一方で、バイオセーフティおよびバイオセキュリティ上の懸念、倫理的な懸念の高まりが市場のさらなる成長を妨げる可能性があります。

ツール別では、オリゴヌクレオチドおよび合成DNAの部門が予測期間中最大の成長を示すと予測されています。医薬品、栄養補助食品、パーソナルケア、フレーバー&フレグランス、プロバイオティクス、グリーンケミカル、工業用酵素などの用途における合成DNA、合成RNA、合成遺伝子への需要の高まりなどの要因が同部門の成長を牽引する見通しです。また、技術別では、ゲノムエンジニアリングの部門が期間中最大のCAGRを示すと予測されています。

当レポートでは、世界の合成生物学の市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、技術・特許の分析、市場規模の推移・予測、ツール・技術・用途・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の影響
  • 技術分析
  • エコシステム分析
  • 特許分析
  • 価格分析
  • ポーターのファイブフォース分析
  • バリューチェーン分析
  • 規制分析

第6章 市場分析・予測:ツール別

  • オリゴヌクレオチド・合成DNA
  • 酵素
  • クローニング技術キット
  • 合成細胞
  • シャーシオーガニズム
  • ゼノ核酸

第7章 市場分析・予測: 技術別

  • 遺伝子合成
  • ゲノムエンジニアリング
  • シーケンシング
  • バイオインフォマティクス
  • クローニング
  • 部位特異的変異導入
  • 測定・モデリング
  • マイクロ流体
  • ナノテクノロジー

第8章 市場分析・予測:用途別

  • 医療
    • 医薬品
    • 創薬・治療
    • 人工組織・組織再生
  • 産業
    • バイオ燃料・再生可能エネルギー
    • 産業用酵素
    • 生体材料・グリーンケミカル
  • 食品・農業
  • 環境
    • バイオレメディエーション
    • バイオセンシング

第9章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 主要企業の成功戦略
  • 市場シェア分析
  • 主要企業の収益シェア分析
  • 企業評価クアドラント
  • 企業評価クアドラント:スタートアップ/SME
  • 企業の製品フットプリント
  • 企業の地理的フットプリント
  • 競合シナリオ

第11章 企業プロファイル

  • 主要企業
    • THERMO FISHER SCIENTIFIC
    • NOVOZYMES
    • MERCK KGAA
    • EUROFINS SCIENTIFIC
    • AGILENT TECHNOLOGIES
    • AMYRIS
    • CODEXIS
    • TWIST BIOSCIENCE
    • GENSCRIPT
    • PRECIGEN
    • GINKGO BIOWORKS
    • SYNTHETIC GENOMICS (SGI)
  • 他の有力企業
    • SYNTHEGO
    • CREATIVE ENZYMES
    • CYRUS BIOTECHNOLOGY
    • ATUM
    • TESELAGEN
    • ARZEDA
    • INTEGRATED DNA TECHNOLOGIES
    • NEW ENGLAND BIOLABS

第12章 付録

目次
Product Code: BT 2910

The global synthetic biology market size is projected to reach USD 30.7 billion by 2026 from USD 9.5 billion in 2021, at a CAGR of 26.5% during the forecast period. Factors such as the increasing demand for synthetic genes and synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing and synthesizing, increasing R&D funding and initiatives in synthetic biology, and increasing investments in the market are propelling the growth of this market. However, rising biosafety, biosecurity, and ethical concerns related to synthetic biology is likely to hamper the growth of this market.

"The oligonucleotides and synthetic DNA segment is expected to grow at the highest rate during the forecast period."

On the basis of tool, the synthetic biology market is broadly segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. In 2020, the oligonucleotides and synthetic DNA segment is expected to register the highest CAGR during the forecast period. This can be attributed to factors such as the rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of applications, such as pharmaceuticals, nutraceuticals, personal care, flavors and fragrances, probiotics, green chemicals, and industrial enzymes.

"The genome engineering segment is expected to grow at the highest CAGR during the forecast period."

On the basis of technology, the market is segmented into gene synthesis, genome engineering, sequencing, bioinformatics, cloning, site-directed mutagenesis, measurement and modeling, microfluidics, nanotechnology.

The genome engineering segment is expected to register the highest CAGR during the forecast period due to factors such as the increasing use of engineering technologies for manipulating complex genomes, growing therapeutics development for cancer and other diseases, and the increasing technological advances in CRISPR-toolbox and DNA synthesis technologies.

"The medical applications segment is expected to grow at the highest CAGR during the forecast period."

Based on application, the synthetic biology market is segmented into medical applications, industrial applications, food & agriculture, and environmental applications. The medical applications segment is expected to register the highest CAGR during the forecast period. Factors such as the extensive research on new and better treatments, coupled with the availability of huge private and public funding for the discovery of novel therapies, is the primary driver for the medical applications segment's growth.

"The Asia Pacific is projected to witness the highest growth during the forecast period."

The synthetic biology market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the synthetic biology market. However, the APAC region is expected to witness the highest growth during the forecast period owing to the growth in the number of pharmaceutical & biopharmaceutical companies, the increasing number of healthcare & life science facilities, and increasing requirements for regulatory compliance in pharmaceutical and biopharmaceutical companies, growing number of international alliances, heavy funding for synthetic biology research, and strong government support. Furthermore, the increasing focus on the Asia Pacific markets due to their low-cost manufacturing advantage also provides growth opportunities for manufacturers.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70%, and Demand Side - 30%
  • By Designation (Supply Side): Managers - 45%, CXOs and Directors - 30%, and Executives- 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:

  • Thermo Fisher Scientific Inc. (US)
  • Merck KGaA (Germany)
  • Agilent Technologies, Inc. (US)
  • Novozymes A/S (Denmark)
  • Ginkgo Bioworks (US)
  • Amyris, Inc. (US)
  • Precigen, Inc. (US)
  • GenScript Biotech Corporation (China)
  • Twist Bioscience (US)
  • Synthetic Genomics, Inc. (US)
  • Codexis, Inc. (US)
  • Synthego Corporation (US)
  • Creative Enzymes (US)
  • Eurofins Scientific (Luxembourg)
  • Cyrus Biotechnology Inc. (US)
  • ATUM (US)
  • TeselaGen (US)
  • Arzeda (US)
  • Integrated DNA Technologies, Inc. (US)
  • New England Biolabs (US).

Research Coverage:

This report provides a detailed picture of the synthetic biology market. It aims at estimating the size and future growth potential of the market across different segments, such as tool, technology, application, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall synthetic biology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION & SCOPE
    • 1.2.1 MARKETS COVERED
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 LIMITATIONS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
    • 2.1.2 PRIMARY RESEARCH
    • FIGURE 2 PRIMARY SOURCES
    • FIGURE 3 SYNTHETIC BIOLOGY MARKET: BREAKDOWN OF PRIMARIES
      • 2.1.2.1 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 - REVENUE SHARE ANALYSIS, 2020
    • FIGURE 5 AVERAGE MARKET SIZE ESTIMATION, 2020
    • FIGURE 6 SYNTHETIC BIOLOGY MARKET: CAGR PROJECTIONS, 2021-2026
    • FIGURE 7 SYNTHETIC BIOLOGY MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 9 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2021 VS. 2026 (USD MILLION)
    • FIGURE 10 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 GEOGRAPHIC ANALYSIS: SYNTHETIC BIOLOGY MARKET

4 PREMIUM INSIGHTS

  • 4.1 SYNTHETIC BIOLOGY MARKET OVERVIEW
    • FIGURE 13 WIDE RANGE OF APPLICATIONS OF SYNTHETIC BIOLOGY DRIVES THE MARKET GROWTH
  • 4.2 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION & COUNTRY (2020)
    • FIGURE 14 MEDICAL APPLICATIONS SEGMENT AND US ACCOUNTED FOR LARGE SHARES OF THE NORTH AMERICAN SYNTHETIC BIOLOGY MARKET IN 2020
  • 4.3 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020
    • FIGURE 15 MEDICAL APPLICATIONS SEGMENT DOMINATED THE MARKET IN 2020
  • 4.4 SYNTHETIC BIOLOGY MARKET: REGIONAL SNAPSHOT
    • FIGURE 16 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 SYNTHETIC BIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 1 SYNTHETIC BIOLOGY MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Wide range of applications of synthetic biology
      • 5.2.1.2 Rising R&D funding and growing initiatives in synthetic biology
    • FIGURE 18 R&D SPENDING OF PHRMA MEMBER COMPANIES, 2005-2019 (USD BILLION)
      • 5.2.1.3 Declining cost of DNA sequencing and synthesizing
    • FIGURE 19 REDUCTION IN COST PER RAW MEGABASE OF DNA SEQUENCING (USD) (2010-2020)
      • 5.2.1.4 Increasing investments in the market
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Biosafety, biosecurity, and ethical concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rise in the need for fuel alternatives
      • 5.2.3.2 Increase in the demand for protein therapeutics and personalized medicines
      • 5.2.3.3 Growth in research on synthetic drugs and vaccines
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Standardization of biological parts
  • 5.3 IMPACT OF COVID-19 ON THE SYNTHETIC BIOLOGY MARKET
  • 5.4 TECHNOLOGY ANALYSIS
    • TABLE 2 COMPARISON OF MODERN GENE EDITING TOOLS
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 20 ECOSYSTEM ANALYSIS: SYNTHETIC BIOLOGY MARKET
    • TABLE 3 SUPPLY CHAIN ECOSYSTEM
  • 5.6 PATENT ANALYSIS
    • FIGURE 21 PATENT APPLICATIONS FOR SYNTHETIC BIOLOGY, JANUARY 2010- DECEMBER 2020
  • 5.7 PRICING ANALYSIS
    • TABLE 4 AVERAGE SELLING PRICE OF SYNTHETIC BIOLOGY PRODUCTS, (2020)
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 5 SYNTHETIC BIOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF SUPPLIERS
    • 5.8.4 BARGAINING POWER OF BUYERS
    • 5.8.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
  • 5.9 VALUE CHAIN ANALYSIS
    • FIGURE 22 VALUE CHAIN ANALYSIS OF THE SYNTHETIC BIOLOGY MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE
  • 5.10 REGULATORY ANALYSIS
    • 5.10.1 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES
    • TABLE 6 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES

6 SYNTHETIC BIOLOGY MARKET, BY TOOL

  • 6.1 INTRODUCTION
    • TABLE 7 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 8 SYNTHETIC BIOLOGY MARKET FOR TOOLS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 9 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TOOLS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 10 EUROPE: SYNTHETIC BIOLOGY MARKET FOR TOOLS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 11 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TOOLS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 12 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TOOLS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 6.2 OLIGONUCLEOTIDES & SYNTHETIC DNA
    • 6.2.1 OLIGONUCLEOTIDES & SYNTHETIC DNA TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
    • TABLE 13 OLIGONUCLEOTIDES & SYNTHETIC DNA: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 14 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 15 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 16 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 17 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 6.3 ENZYMES
    • 6.3.1 DEVELOPMENT OF ENZYMES HELPED EVOLVE NEW THERAPIES FOR A RANGE OF DISEASES
    • TABLE 18 ENZYMES: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 19 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 20 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 21 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 22 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 6.4 CLONING TECHNOLOGY KITS
    • 6.4.1 NEED FOR THE CREATION OF ARTIFICIAL DNA AND ASSEMBLY DRIVING THE GROWTH OF THE SEGMENT
    • TABLE 23 CLONING TECHNOLOGY KITS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 24 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 25 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 26 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 27 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 6.5 SYNTHETIC CELLS
    • 6.5.1 SYNTHETIC CELLS TO ALLOW TAILORING BIOLOGICS TO INCREASE ADOPTION IN THE COMING YEARS
    • TABLE 28 SYNTHETIC CELLS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 29 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 30 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 31 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 32 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 6.6 CHASSIS ORGANISMS
    • 6.6.1 INCREASING DEMAND FOR FOSSIL FUELS TO PROPEL THE DEMAND FOR CHASSIS ORGANISMS
    • TABLE 33 CHASSIS ORGANISMS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 34 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 35 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 36 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 37 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 6.7 XENO-NUCLEIC ACIDS
    • 6.7.1 XENO-NUCLEIC ACIDS BEING INCREASINGLY RESEARCHED DUE TO THE GROWING DEMAND FOR BREAKTHROUGH MEDICINES
    • TABLE 38 XENO-NUCLEIC ACIDS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 39 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 40 EUROPE: SYNTHETIC BIOLOGY MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 41 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 42 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)

7 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 43 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 44 SYNTHETIC BIOLOGY MARKET FOR TECHNOLOGY, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 45 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TECHNOLOGY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 46 EUROPE: SYNTHETIC BIOLOGY MARKET FOR TECHNOLOGY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TECHNOLOGY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 48 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TECHNOLOGY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 7.2 GENE SYNTHESIS
    • 7.2.1 GENE SYNTHESIS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
    • TABLE 49 GENE SYNTHESIS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 50 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 51 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 52 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 53 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 7.3 GENOME ENGINEERING
    • 7.3.1 INCREASING DEMAND FOR SYNTHETIC DNA AND GENES TO DRIVE THE MARKET GROWTH
    • TABLE 54 GENOME ENGINEERING: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 55 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 56 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 57 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 58 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 7.4 SEQUENCING
    • 7.4.1 NGS TECHNOLOGY RAPIDLY BECOMING AN INDISPENSABLE AND UNIVERSAL TOOL FOR BIOLOGICAL RESEARCH
    • TABLE 59 SEQUENCING: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 60 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 61 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 62 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 63 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 7.5 BIOINFORMATICS
    • 7.5.1 INCREASING USE OF BIOINFORMATICS TECHNOLOGY DUE TO THE RISING NEED FOR DATA MANAGEMENT AND CURATION
    • TABLE 64 BIOINFORMATICS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 65 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 66 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 67 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 68 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 7.6 CLONING
    • 7.6.1 CLONING AIDS IN BUILDING NEW GENETIC MODULES/PATHWAYS ENABLING RAPID ADVANCES IN RESEARCH ACROSS INDUSTRIES
    • TABLE 69 CLONING: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 70 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 71 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 72 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 73 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 7.7 SITE-DIRECTED MUTAGENESIS
    • 7.7.1 WIDE APPLICATIONS IN GENETIC ENGINEERING, DNA ASSEMBLY, AND CLONING TECHNOLOGIES DRIVING THE SEGMENT GROWTH
    • TABLE 74 SITE-DIRECTED MUTAGENESIS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 75 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 76 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 77 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 78 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 7.8 MEASUREMENT & MODELING
    • 7.8.1 COMPUTATIONAL MODELING TO AID THE GROWTH OF THE SEGMENT DURING THE FORECAST PERIOD
    • TABLE 79 MEASUREMENT & MODELING: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 80 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 81 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 82 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 83 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 7.9 MICROFLUIDICS
    • 7.9.1 DROPLET MICROFLUIDICS GAINING WIDE RECOGNITION IN THE FIELD OF SYNTHETIC BIOLOGY
    • TABLE 84 MICROFLUIDICS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 85 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 86 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 87 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 88 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 7.10 NANOTECHNOLOGY
    • 7.10.1 CONVERGENCE BETWEEN SYNTHETIC BIOLOGY AND NANOTECHNOLOGY AIDS IN BUILDING COMPLEX BODIES
    • TABLE 89 NANOTECHNOLOGY: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 90 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 91 EUROPE: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 92 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 93 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)

8 SYNTHETIC BIOLOGY MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 94 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 8.2 MEDICAL APPLICATIONS
    • TABLE 95 MEDICAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 96 MEDICAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 97 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 98 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 100 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • 8.2.1 PHARMACEUTICALS
      • 8.2.1.1 Potential of synthetic biology techniques in the development and manufacturing of APIs and small molecules drives the growth of the segment
    • TABLE 101 PHARMACEUTICALS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 102 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 103 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 104 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 105 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • 8.2.2 DRUG DISCOVERY AND THERAPEUTICS
    • TABLE 106 DRUG DISCOVERY AND THERAPEUTICS: SYNTHETIC BIOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 107 DRUG DISCOVERY AND THERAPEUTICS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 108 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 109 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 111 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
      • 8.2.2.1 Cancer detection & diagnostics
        • 8.2.2.1.1 Increasing investments in cancer research to drive the growth of the segment
    • TABLE 112 SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 113 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 114 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 115 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 116 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
      • 8.2.2.2 Other drug discovery and therapeutic applications
    • TABLE 117 SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 118 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 119 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 121 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • 8.2.3 ARTIFICIAL TISSUE & TISSUE REGENERATION
    • TABLE 122 ARTIFICIAL TISSUE & TISSUE REGENERATION: SYNTHETIC BIOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 123 ARTIFICIAL TISSUE & TISSUE REGENERATION: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 124 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 125 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 126 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 127 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
      • 8.2.3.1 Bio-synthesis
        • 8.2.3.1.1 Bio-synthesis dominating the market with its increasing adoption for creating artificial genomes
    • TABLE 128 SYNTHETIC BIOLOGY MARKET FOR BIO-SYNTHESIS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 129 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIO-SYNTHESIS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 130 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIO-SYNTHESIS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 131 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIO-SYNTHESIS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 132 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIO-SYNTHESIS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
      • 8.2.3.2 Stem cell regulation
        • 8.2.3.2.1 Use of synthetic biology in stem cell regeneration and reprogramming somatic cells to drive the market growth
    • TABLE 133 SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 134 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 135 EUROPE: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 137 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
      • 8.2.3.3 Other artificial tissue and tissue regeneration applications
    • TABLE 138 SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 139 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 140 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 142 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE & TISSUE REGENERATION APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 8.3 INDUSTRIAL APPLICATIONS
    • TABLE 143 INDUSTRIAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 INDUSTRIAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 145 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 146 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 147 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 148 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • 8.3.1 BIOFUEL AND RENEWABLE ENERGY
      • 8.3.1.1 Advantages of using genetically engineered organisms for the synthetic production of biofuels driving the market growth
    • TABLE 149 SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 150 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 151 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 152 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 153 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • 8.3.2 INDUSTRIAL ENZYMES
    • TABLE 154 INDUSTRIAL ENZYMES: SYNTHETIC BIOLOGY MARKET, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 155 INDUSTRIAL ENZYMES: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 156 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 157 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 158 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 159 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
      • 8.3.2.1 Textile industry
        • 8.3.2.1.1 Synthetic biology to replace traditional raw materials in the textile industry
    • TABLE 160 SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 161 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 162 EUROPE: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 163 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 164 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
      • 8.3.2.2 Paper industry
        • 8.3.2.2.1 Increasing use of enzymes in the pulp and paper industry
    • TABLE 165 SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 166 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 167 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 168 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 169 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
      • 8.3.2.3 Consumer care industry
    • TABLE 170 CONSUMER CARE INDUSTRY: SYNTHETIC BIOLOGY MARKET BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 171 CONSUMER CARE INDUSTRY: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 172 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 173 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 174 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 175 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
        • 8.3.2.3.1 Skincare & cosmetics
  • 8.3.2.3.1.1 Enzymes in skincare cosmetics protect skin from harmful external agents causing the breakdown of collagen
    • TABLE 176 SYNTHETIC BIOLOGY MARKET FOR SKINCARE & COSMETICS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 177 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKIN CARE & COSMETICS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 178 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SKIN CARE & COSMETICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 179 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SKIN CARE & COSMETICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 180 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKIN CARE & COSMETICS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
        • 8.3.2.3.2 Other consumer care products
    • TABLE 181 SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 182 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 183 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 184 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 185 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
      • 8.3.2.4 Other industries
    • TABLE 186 SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 187 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 188 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 189 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 190 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • 8.3.3 BIOMATERIALS & GREEN CHEMICALS
      • 8.3.3.1 Use of synthetic biology for preparing silk-based proteins
    • TABLE 191 BIOMATERIALS AND GREEN CHEMICALS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 192 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 193 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 194 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 195 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 8.4 FOOD & AGRICULTURE
    • 8.4.1 SYNTHETIC BIOLOGY TECHNIQUES PRODUCE METABOLITES, HEALTH PRODUCTS, AND PROCESSING AIDS IN THE FOOD AND AGRICULTURE INDUSTRY
    • TABLE 196 FOOD AND AGRICULTURE: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 197 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 198 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 199 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 200 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
  • 8.5 ENVIRONMENTAL APPLICATIONS
    • TABLE 201 ENVIRONMENTAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 202 ENVIRONMENTAL APPLICATIONS: SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 203 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 204 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 205 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 206 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • 8.5.1 BIOREMEDIATION
      • 8.5.1.1 Bioremediation helps in cleaning oil spills, preventing chemical pollution, and plugging nuclear leakages
    • TABLE 207 SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 208 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 209 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 210 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 211 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • 8.5.2 BIOSENSING
      • 8.5.2.1 Biosensors utilize microalgae due to high reproductive rates and ease of culturing
    • TABLE 212 SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 213 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 214 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 215 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)
    • TABLE 216 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY/REGION, 2019-2026 (USD MILLION)

9 SYNTHETIC BIOLOGY MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 217 SYNTHETIC BIOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 23 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET SNAPSHOT
    • TABLE 218 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 219 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 220 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 221 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 222 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 223 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 224 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 225 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 226 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 227 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 228 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US to dominate the North American synthetic biology market
    • TABLE 229 US: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 230 US: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 231 US: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 232 US: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 233 US: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 234 US: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 235 US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 236 US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 237 US: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 238 US: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Strong research infrastructure and availability of funding to support market growth
    • TABLE 239 CANADA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 240 CANADA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 241 CANADA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 242 CANADA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 243 CANADA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 244 CANADA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 245 CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 246 CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 247 CANADA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 248 CANADA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 249 EUROPE: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 250 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 251 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 252 EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 253 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 254 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 255 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 256 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 257 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 258 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 259 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 The rapidly growing pharmaceutical market to drive the market growth
    • TABLE 260 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 261 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 262 GERMANY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 263 GERMANY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 264 GERMANY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 265 GERMANY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 266 GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 267 GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 268 GERMANY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 269 GERMANY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 The UK to hold the largest share of the European market
    • TABLE 270 UK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 271 UK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 272 UK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 273 UK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 274 UK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 275 UK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 276 UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 277 UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 278 UK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 279 UK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Research across all industries to be strongly supported by the government
    • TABLE 280 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 281 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 282 FRANCE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 283 FRANCE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 284 FRANCE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 285 FRANCE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 286 FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 287 FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 288 FRANCE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 289 FRANCE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.4 SWITZERLAND
      • 9.3.4.1 Market growth to be primarily driven by the well-established pharmaceutical & biotechnology industry in the country
    • TABLE 290 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 291 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 292 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 293 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 294 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 295 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 296 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 297 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 298 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 299 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.5 DENMARK
      • 9.3.5.1 Denmark to have the third-largest commercial drug development pipeline in Europe
    • TABLE 300 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 301 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 302 DENMARK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 303 DENMARK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 304 DENMARK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 305 DENMARK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 306 DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 307 DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 308 DENMARK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 309 DENMARK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.6 ITALY
      • 9.3.6.1 Growth in this market to be mainly driven by increasing life science R&D in the country, funded by both public and private organizations
    • TABLE 310 ITALY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 311 ITALY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 312 ITALY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 313 ITALY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 314 ITALY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 315 ITALY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 316 ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 317 ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 318 ITALY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 319 ITALY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.7 SPAIN
      • 9.3.7.1 Spain to have a well-established network of research centers, universities, and hospitals, forming an ideal environment for research
    • TABLE 320 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 321 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 322 SPAIN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 323 SPAIN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 324 SPAIN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 325 SPAIN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 326 SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 327 SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 328 SPAIN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 329 SPAIN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.8 REST OF EUROPE
    • TABLE 330 ROE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 331 ROE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 332 ROE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 333 ROE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 334 ROE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 335 ROE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 336 ROE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 337 ROE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 338 ROE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 339 ROE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 24 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET SNAPSHOT
    • TABLE 340 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 341 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 342 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 343 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 344 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 345 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 346 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 347 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 348 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 349 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 350 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 Growth in R&D to enhance technological capabilities in the country driving the demand for high-quality research tools
    • TABLE 351 CHINA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 352 CHINA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 353 CHINA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 354 CHINA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 355 CHINA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 356 CHINA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 357 CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 358 CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 359 CHINA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 360 CHINA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Large number of research initiatives toward the development of precision medicine supporting the market growth
    • TABLE 361 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 362 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 363 JAPAN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 364 JAPAN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 365 JAPAN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 366 JAPAN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 367 JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 368 JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 369 JAPAN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 370 JAPAN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.4.3 AUSTRALIA
      • 9.4.3.1 Increasing focus of the healthcare system on precision medicine to offer significant growth opportunities
    • TABLE 371 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 372 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 373 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 374 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 375 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 376 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 377 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 378 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 379 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 380 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing pharma R&D activities and government funding for the biotechnology industry driving the market growth
    • TABLE 381 INDIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 382 INDIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 383 INDIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 384 INDIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 385 INDIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 386 INDIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 387 INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 388 INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 389 INDIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 390 INDIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.4.5 REST OF ASIA PACIFIC
    • TABLE 391 ROAPAC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 392 ROAPAC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 393 ROAPAC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 394 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 395 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 396 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 397 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 398 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 399 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 400 ROAPAC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 401 LATAM: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 402 LATAM: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 403 LATAM: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 404 LATAM: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 405 LATAM: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 406 LATAM: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 407 LATAM: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 408 LATAM: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 409 LATAM: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 410 LATAM: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.5.1 BRAZIL
      • 9.5.1.1 Growing pharmaceutical industry to drive the market growth
    • TABLE 411 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 412 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 413 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 414 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 415 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 416 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 417 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 418 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 419 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 420 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.5.2 MEXICO
      • 9.5.2.1 Increasing support for biotechnology infrastructure development to drive the market growth
    • TABLE 421 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 422 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 423 MEXICO: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 424 MEXICO: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 425 MEXICO: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 426 MEXICO: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 427 MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 428 MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 429 MEXICO: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 430 MEXICO: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 9.5.3 REST OF LATIN AMERICA
    • TABLE 431 ROLA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 432 ROLA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 433 ROLA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 434 ROLA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 435 ROLA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 436 ROLA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 437 ROLA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 438 ROLA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 439 ROLA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 440 ROLA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
  • 9.6 MIDDLE EAST AND AFRICA
    • 9.6.1 INCREASING PARTNERSHIPS AMONG GLOBAL PLAYERS WITH GOVERNMENT ORGANIZATIONS IN THE REGION TO SUPPORT THE MARKET GROWTH
    • TABLE 441 MEA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2019-2026 (USD MILLION)
    • TABLE 442 MEA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 443 MEA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 444 MEA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 445 MEA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 446 MEA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 447 MEA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 448 MEA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2019-2026 (USD MILLION)
    • TABLE 449 MEA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 450 MEA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • FIGURE 25 KEY PLAYER STRATEGIES IN THE SYNTHETIC BIOLOGY MARKET, 2018 - 2021
  • 10.3 MARKET SHARE ANALYSIS
    • FIGURE 26 SYNTHETIC BIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
  • 10.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
  • 10.5 COMPANY EVALUATION QUADRANT
    • 10.5.1 STAR
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE
    • 10.5.4 EMERGING COMPANIES
    • FIGURE 28 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2020
  • 10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 29 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
  • 10.7 COMPANY PRODUCT FOOTPRINT
    • TABLE 451 PRODUCT PORTFOLIO ANALYSIS: SYNTHETIC BIOLOGY MARKET (2020)
  • 10.8 COMPANY GEOGRAPHIC FOOTPRINT
    • TABLE 452 GEOGRAPHIC REVENUE MIX: SYNTHETIC BIOLOGY MARKET (2020)
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 SYNTHETIC BIOLOGY MARKET: PRODUCT LAUNCHES, JANUARY 2018 - APRIL 2021
    • 10.9.2 SYNTHETIC BIOLOGY MARKET: DEALS, JANUARY 2018-APRIL 2021
    • 10.9.3 SYNTHETIC BIOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2018 - APRIL 2021

11 COMPANY PROFILE

  • 11.1 KEY MARKET PLAYERS
  • (Business overview, Products offered, Recent developments, SWOT analysis, MNM view)**
    • 11.1.1 THERMO FISHER SCIENTIFIC
    • FIGURE 30 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
    • 11.1.2 NOVOZYMES
    • FIGURE 31 NOVOZYMES: COMPANY SNAPSHOT (2020)
    • 11.1.3 MERCK KGAA
    • FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2020)
    • 11.1.4 EUROFINS SCIENTIFIC
    • FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020)
    • 11.1.5 AGILENT TECHNOLOGIES
    • FIGURE 34 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020)
    • 11.1.6 AMYRIS
    • FIGURE 35 AMYRIS: COMPANY SNAPSHOT (2020)
    • 11.1.7 CODEXIS
    • FIGURE 36 CODEXIS: COMPANY SNAPSHOT (2020)
    • 11.1.8 TWIST BIOSCIENCE
    • FIGURE 37 TWIST BIOSCIENCE: COMPANY SNAPSHOT
    • 11.1.9 GENSCRIPT
    • FIGURE 38 GENSCRIPT: COMPANY SNAPSHOT (2020)
    • 11.1.10 PRECIGEN
    • FIGURE 39 PRECIGEN: COMPANY SNAPSHOT (2020)
    • 11.1.11 GINKGO BIOWORKS
    • 11.1.12 SYNTHETIC GENOMICS (SGI)
  • 11.2 OTHER PLAYERS
    • 11.2.1 SYNTHEGO
    • 11.2.2 CREATIVE ENZYMES
    • 11.2.3 CYRUS BIOTECHNOLOGY
    • 11.2.4 ATUM
    • 11.2.5 TESELAGEN
    • 11.2.6 ARZEDA
    • 11.2.7 INTEGRATED DNA TECHNOLOGIES
    • 11.2.8 NEW ENGLAND BIOLABS
  • *Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS